Tibco Software has launched Tibco Spotfire Clinical, an in-memory analytics platform designed to improve clinical trials and accelerate drug development.
Tibco Spotfire Clinical will be demonstrated at the 46th Drug Information Association annual meeting, Through highly visual and interactive exploration of clinical data, Spotfire Clinical will enable actionable decisions that enhance patient safety, streamline operations and accelerate time-to-market for new medication and devices.
The company said this leads to better medical outcomes for patients and allowing life-sciences organisations to achieve shorter development cycles and faster approvals of new medications.
Clinical development teams can quickly visualise and interact with large volumes of operational, clinical and safety data in a single interface to support forward-looking decisions, rather than retrospective tracking of results.
Tibco said that be leveraging the integrated S+/R statistics and predictive analytics capabilities of the Tibco Spotfire analytics platform, users will be able to conduct advanced what-if scenarios and sophisticated analysis to gain key insights into data, without the intervention of IT resources or biostatisticians.
Spotfire Clinical will integrate out-of-the box with systems including Oracle Clinical and Oracle Remote Data Capture.
With these integrations, clinical development teams can leverage interactive visualisations and S+/R-based predictive analytics to rapidly explore their clinical data stored in clinical data management and electronic data capture systems.
Pharmaceutical, biotechnology, medical device and contract research organisations using Spotfire Clinical will be able to visually interact with and identify patterns and trends in their data, enabling decisions that will shorten the time between critical development gates and meet operational milestones more quickly.
Tibco Spotfire Clinical will provide a centralised and integrated view of clinical, operational and safety data in a highly visual interface that lets clinical teams easily customise and share their findings through mash-ups, portals or interactive dashboards.
New web mash-up application programming interfaces (APIs) will let users merge operational, clinical, safety and pharmacovigilance data to identify patterns or outliers in the data to support superior decision-making.
It can export visualisations to PDF format or interact over the web through the Tibco Spotfire web player, making it easier for clinical teams to share important findings with key stakeholders.
Clinicians can detect, assess and understand adverse events leading to better prevention by integrating with various signal detection systems to mitigate risk associated with ongoing clinical studies.
The speed and ease with which users can drill into the data - down to the patient level - and view various safety profiles using what-if scenarios empowers medical reviewers and clinicians to quickly spot adverse effects or remove patients from a trial before they are at risk.
Users can analyse Kaplan-Meier and cumulative incidence data streams using the built-in S+ and R compatibility of Spotfire Clinical, without the intervention of IT or biostatisticians.
They can merge, visualise and explore adverse drug reaction information, case processing and other medical data within Spotfire Clinical to prepare for periodic safety update reports (PSUR).
